Início › Câncer Metastático › Colorado › Aurora
Ensaios clínicos de Câncer Metastático em Aurora, CO
25 estudos para Câncer Metastático estão buscando participantes em locais em Aurora e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RecrutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- UCHealth University of Colorado Hospital, Aurora
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecrutandoFase 1
- University of Colorado Anschutz Medical Campus, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecrutandoFase 3
- Research Site, Aurora
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecrutandoFase 1/2
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- University of Colorado Cancer Center, Aurora
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecrutandoFase 1/2
- Rocky Mountain Cancer Centers,LLP, Aurora
- Clinical and Translational Research Center(CTRC), Aurora
- University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
- e mais 2
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- University of Colorado Health Hospital, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- University of Colorado, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- University of Colorado, Aurora
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecrutandoFase 1/2
- Crinetics Study Site, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecrutandoFase 1
- University of Colorado - Aurora Cancer Center, Aurora
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- University of Colorado Cancer Center, Aurora
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RecrutandoFase 1/2
- University of Colorado Cancer Center, Aurora
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecrutandoFase 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecrutandoFase 1/2
- University of Colorado Cancer Center, Aurora
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecrutandoFase 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
Venetoclax Basket Trial for High Risk Hematologic Malignancies
RecrutandoFase 1
- Children's Hospital Colorado, Aurora
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RecrutandoFase 3
- University of Colorado Cancer Center, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
RecrutandoFase 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
RecrutandoFase 1
- University of Colorado School of Medicine, Aurora
Ensaios de Câncer Metastático em outras cidades
- Houston, TX104 estudos
- New York City, NY93 estudos
- Nashville, TN70 estudos
- Boston, MA63 estudos
- Los Angeles, CA57 estudos
- St. Louis, MO54 estudos
- Arlington, VA53 estudos
- Philadelphia, PA46 estudos
- Chicago, IL45 estudos
- San Antonio, TX44 estudos
- Washington, DC43 estudos
- Dallas, TX42 estudos
Outros estudos em Aurora
- Câncer (todos os tipos)35 estudos
- Câncer Colorretal32 estudos
- Câncer de Pulmão de Não Pequenas Células31 estudos
- Câncer de Mama28 estudos
- Câncer de Ovário25 estudos
- Diabetes Tipo 123 estudos
- Obesidade22 estudos
- Câncer de Próstata19 estudos
- Câncer de Pulmão19 estudos
- Insuficiência Cardíaca18 estudos
- Melanoma18 estudos
- Leucemia Mieloide Aguda16 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.